PHATHOM PHARMACEUTICALS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 13 Feb 2026)
What this means for you
Registered since 10 Nov 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88316950
- Registration number
- 6195918
- Mark type
- Stylized text
- Filed
- 26 Feb 2019
- Published for opposition
- 02 Jul 2019
- Registered
- 10 Nov 2020
- Attorney of record
- Edmund J. Ferdinand, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of gastrointestinal related diseases, disorders and infections
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- PHATHOM PHARMACEUTICALS, INC., FLORHAM PARK, NJ, US
- PHATHOM PHARMACEUTICALS, INC., FLORHAM PARK, NJ, US
- NORTH BRIDGE IV, INC., SEATTLE, WA, US
- NORTH BRIDGE IV, INC., SEATTLE, WA, US
Prosecution history
- 13 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Feb 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Feb 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Nov 2025 — TEAS SECTION 8 & 15 RECEIVED
- 10 Nov 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 01 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 01 Feb 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 01 Feb 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Sept 2021 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 10 Nov 2020 — REGISTERED-PRINCIPAL REGISTER
- 07 Oct 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Oct 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Oct 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Sept 2020 — USE AMENDMENT FILED
- 05 Oct 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL